China has a person with bird flu vaccine production reserve conditions

National Science and Technology Information Service Network
2009-2-16

National Food and Drug Administration recently launched a pandemic influenza virus inactivated vaccine (commonly known as "Human use of avian influenza vaccine")批签发synchronization procedures. At present, our country has a pandemic influenza virus vaccine production reserve conditions happen in a pandemic influenza or emergency situations, by the state to start for the pandemic influenza vaccination.

This year, our country emerged for many cases of human bird flu cases, the State Food and Drug Administration official said, given the current avian influenza prevention and control of the situation, to safeguard public health, the State Food and Drug Authority before the official start of the pandemic influenza vaccine批签发synchronization process, namely, the production enterprises, regulatory testing and drug testing批签发at the same time, and vaccine production conducted a site inspection.

Pandemic influenza viruses are inactivated vaccine by Beijing Kexing Biological Products Co., Ltd. and the Chinese Center for Disease Control and Prevention jointly developed by commodity called hope Seoul to Fuk, applies to 18-year-old to 60-year-old adults. The vaccine by the State Food and Drug Administration approval process through, inter alia, the approval in April 2008 on access to medicines Register documents.

National Food and Drug Administration pointed out that to deal with pandemic influenza are global common issues faced by, and as a result of limited production cycle must be before an outbreak of pandemic influenza on reserves a certain amount of vaccine to ensure that the epidemic emerged in the early days of to the appropriate people to carry out vaccination.

Governments are actively under the framework of the World Health Organization strategy, many countries have reserves of a large number of H5N1 vaccine. In our country, I hope that Seoul Laifu documents are currently the only access to the H5N1 pandemic influenza vaccine.